Hermetica Superfood Encyclopedia
The Short Answer
Mikania micrantha aerial parts contain phenolic acids (notably caffeic acid with FRAP up to 20.86 mmol/g), flavonoids, and sesquiterpene lactones (deoxymikanolide, mikanolide) that exert antioxidant activity via free radical scavenging and antimicrobial activity via membrane disruption. In vitro, isolated phenolics achieved ABTS SC50 values of 0.31–4.86 µM—superior to L-ascorbic acid at 10.48 µM—and ethanolic leaf extracts (300 mg/mL) produced inhibition zones of 12.67–14.33 mm against Staphylococcus aureus and Propionibacterium acnes, supporting its traditional use in wound care in Papua New Guinea.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordMikania micrantha benefits
Mile-a-Minute Weed — botanical close-up
Health Benefits
**Antioxidant Activity**: Phenolic compounds including caffeic acid (FRAP 20
86 mmol/g) and benzyl glucoside derivatives achieve ABTS SC50 values as low as 0.31 µM in vitro, surpassing L-ascorbic acid, suggesting potent free radical neutralization capacity in crude extracts.
**Wound Healing Support**
In PNG traditional medicine, fresh leaves are applied topically to wounds; ethanolic extracts show inhibition zones of 12.67 mm against S. aureus and 14.33 mm against P. acnes, providing a plausible antimicrobial basis for this practice.
**Antimicrobial Properties**
Sesquiterpene lactones—deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, and dihydromikanolide—isolated from leaves contribute to broad-spectrum antimicrobial action, likely by disrupting microbial membrane integrity.
**Anti-inflammatory Potential**
Flavonoids and phenolic acids identified across leaf and stem extracts are reported in ethnobotanical reviews as contributing to anti-inflammatory effects, though specific molecular targets in Mikania micrantha have not yet been characterized beyond in vitro assays.
**Anti-dermatophytic Activity**
Traditional use records (53 ethnobotanical entries) document application against skin fungal infections; flavonoid-rich fractions are hypothesized to inhibit dermatophyte growth, consistent with known mechanisms of structurally similar flavonoids.
**Anthelmintic Use**
Ethnobotanical records across tropical Asia and Pacific Island communities describe use of whole-plant preparations against intestinal parasites, attributed provisionally to terpene lactone content, though no controlled studies confirm efficacy.
**Anti-diabetic Potential**
Traditional use against diabetes mellitus is recorded across multiple Asian communities; phenolic acids such as caffeic acid and p-coumaric acid are established inhibitors of α-glucosidase in related plants, though this activity has not been directly confirmed for M. micrantha extracts.
Origin & History
Natural habitat
Mikania micrantha is native to Central and South America but has become a highly invasive pantropical weed now widespread across South and Southeast Asia, the Pacific Islands, and sub-Saharan Africa. It thrives in disturbed habitats, forest edges, and agricultural margins at low to mid elevations, growing rapidly in warm, humid, high-rainfall environments including Papua New Guinea, India, and the Philippines. It is not intentionally cultivated for medicinal purposes; plant material for study is typically wild-harvested from its naturalized range.
“Mikania micrantha has accumulated at least 53 recorded ethnobotanical uses across tropical Asia, the Pacific Islands, and parts of Africa, reflecting its availability as a widely distributed invasive weed adopted into local healing traditions wherever it naturalized. In Papua New Guinea, fresh leaf application for wound management represents one of the most documented Pacific Island uses and is consistent with reported antimicrobial properties of the plant's sesquiterpene lactones and phenolics. In India and Southeast Asia, the plant is used in folk systems for skin diseases, fever, intestinal parasites, and diabetes, demonstrating a convergent recognition of its biological activity across unrelated cultural traditions. Despite its traditional prominence, Mikania micrantha is primarily regarded as an agricultural pest in most of its introduced range, and its medicinal applications have not been incorporated into any formal traditional medicine pharmacopoeia.”Traditional Medicine
Scientific Research
All available evidence for Mikania micrantha derives from in vitro phytochemical characterization and ethnobotanical surveys; no human clinical trials, animal pharmacokinetic studies, or randomized controlled experiments have been published as of the latest available sources. Phytochemical studies have isolated and characterized at least 14 phenolic and terpene compounds from aerial parts, quantifying antioxidant activity via ABTS, DPPH, and FRAP assays with internal comparators (L-ascorbic acid, Trolox). Ethnobotanical review of 53 use records provides breadth of traditional application across tropical Asia and the Pacific but does not constitute controlled evidence of efficacy or safety. The evidence base is therefore preclinical and preliminary; extrapolation of in vitro antioxidant or antimicrobial data to human health outcomes is not scientifically justified at this time.
Preparation & Dosage
Traditional preparation
**Traditional Poultice**
Fresh leaves crushed and applied directly to wounds or skin lesions as practiced in Papua New Guinea; no standardized quantity or frequency established.
**Hot Water Decoction (Leaf)**
37 mg GAE/g extract; no safe or effective human dose defined
Highest extractive yield at 27.64% w/w; total phenolic content 335.5 ± 2..
**Methanolic Extract (Leaf)**
72 mg GAE/g; used in in vitro studies only, not suitable for direct human consumption without further processing
Yield 18.79% w/w; TPC 241.91 ± 1..
**Ethanolic Extract (Leaf/Stem)**
300 mg/mL used in antimicrobial assays; this concentration is experimental and not a supplement dose
Concentration of .
**Standardization**
No commercial standardization to specific marker compounds (e.g., caffeic acid, deoxymikanolide) has been established; no supplement-grade product exists.
**Dosage Note**
No effective or maximum safe dose has been determined for any route of administration in humans; all preparations described are research-grade only.
Nutritional Profile
Mikania micrantha aerial parts contain carbohydrates, vitamins, and minerals at unquantified concentrations alongside its pharmacologically active phytochemicals; the plant has not been characterized as a food or nutritional ingredient. Total phenolic content is high in aqueous and hydroalcoholic extracts (up to 335.5 mg GAE/g dry extract weight in hot water leaf extract), indicating a dense phenolic matrix that likely includes flavonoid glycosides, hydroxycinnamic acids (caffeic acid, p-coumaric acid), and hydroxybenzoic acid derivatives. Sesquiterpene lactones (mikanolide, deoxymikanolide, scandenolide) are present in leaf material and represent secondary metabolites with no nutritional caloric value. Bioavailability of these compounds from whole plant material or crude extracts has not been studied; absorption, distribution, metabolism, and excretion (ADME) data are entirely absent from the published literature.
How It Works
Mechanism of Action
The antioxidant mechanism centers on direct hydrogen atom or electron transfer from phenolic hydroxyl groups—particularly those of caffeic acid (compound 9), protocatechuic aldehyde (12), and benzyl glucoside derivatives (1, 2, 3)—to reactive oxygen and nitrogen species, with DPPH SC50 values of 16.24–21.67 µM and ABTS SC50 values of 0.31–4.86 µM confirming potent radical quenching capacity. Antimicrobial action is attributed primarily to sesquiterpene lactones (deoxymikanolide, mikanolide) and phenolics disrupting microbial cell membrane permeability and integrity, though specific protein or lipid targets have not been identified by proteomic or lipidomic studies. No receptor-level, enzyme-inhibition kinetics, or gene-expression data have been published for M. micrantha; mechanistic inferences are extrapolated from structural analogy with pharmacologically characterized compounds in related species. The high total phenolic content of hot water leaf extracts (335.5 ± 2.37 mg gallic acid equivalents/g) suggests a cumulative, multi-target antioxidant effect rather than a single dominant pathway.
Clinical Evidence
No clinical trials assessing Mikania micrantha in human subjects have been identified in the peer-reviewed literature. There are no published data on human pharmacokinetics, effective doses, measurable biomarkers, or patient-reported outcomes. The antimicrobial and antioxidant activities documented in laboratory settings represent hypothesis-generating findings only and have not been validated in phase I, II, or III trials. Confidence in any clinical recommendation is therefore very low; use in PNG traditional medicine for wound care remains empirical and unsupported by controlled human evidence.
Safety & Interactions
No formal safety studies, toxicology assessments, maximum tolerated dose determinations, or adverse event monitoring studies have been conducted for Mikania micrantha in humans or validated animal models, meaning its safety profile is genuinely unknown. The plant is classified as one of the world's most damaging invasive weeds and contains biologically active sesquiterpene lactones that, in related genera, are associated with contact dermatitis and cytotoxicity at higher concentrations, raising theoretical but unquantified toxicity concerns. No drug interaction data exist; however, given the presence of caffeic acid and flavonoids—classes known to modulate CYP450 enzymes in other species—interactions with anticoagulants, immunosuppressants, or hypoglycemic agents cannot be excluded. Pregnant and lactating individuals, children, and immunocompromised patients should avoid internal use given the complete absence of safety data; external traditional poultice use carries unknown but potentially non-trivial dermal sensitization risk.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Mikania micrantha KunthMile-a-minute weedBitter vineAmerican ropeMikania scandens (misapplied)
Frequently Asked Questions
What is Mikania micrantha used for in traditional medicine?
In Papua New Guinea and across tropical Asia, Mikania micrantha leaves are applied to wounds, skin infections, and rashes, and the plant is used internally for fever, intestinal parasites, and diabetes based on 53 documented ethnobotanical records. These uses are empirical and rooted in traditional practice; they have not been validated by controlled clinical trials or standardized preparation guidelines.
Does Mikania micrantha have proven antimicrobial activity?
In vitro, ethanolic extracts at 300 mg/mL produced inhibition zones of 12.67 ± 0.58 mm against Staphylococcus aureus and 14.33 ± 2.08 mm against Propionibacterium acnes, and sesquiterpene lactones including deoxymikanolide and mikanolide have been isolated as antimicrobial constituents. However, these findings are laboratory-based only; antimicrobial efficacy has not been confirmed in animal infection models or human clinical trials.
Is mile-a-minute weed safe to use medicinally?
The safety of Mikania micrantha for any medicinal use has not been formally evaluated; no toxicology studies, maximum safe dose determinations, or human adverse event data have been published. As an invasive weed containing biologically active sesquiterpene lactones, it carries theoretical risks of dermal sensitization and systemic toxicity that have not been ruled out, and internal use cannot currently be recommended.
What are the main bioactive compounds in Mikania micrantha?
The plant's aerial parts contain caffeic acid, p-coumaric acid, protocatechuic aldehyde, hydroquinone, and novel phenolic glucosides (including benzyl 5-O-β-D-glucopyranosyl-2,5-dihydroxybenzoate) alongside sesquiterpene lactones—deoxymikanolide, mikanolide, scandenolide, and their dihydro derivatives—and a sulfated flavonoid profile. Hot water leaf extracts show the highest total phenolic content at 335.5 ± 2.37 mg gallic acid equivalents per gram of extract.
What is the antioxidant potency of Mikania micrantha compared to vitamin C?
Several isolated phenolic compounds from Mikania micrantha, including caffeic acid and benzyl glucoside derivatives, achieved ABTS radical scavenging SC50 values of 0.31–4.86 µM, substantially lower (more potent) than L-ascorbic acid at 10.48 µM in the same assay system. These in vitro results indicate high antioxidant capacity per mole of compound but cannot be directly translated to equivalent human dietary or supplement doses due to the absence of bioavailability data.
What is the difference between fresh Mikania micrantha leaves and standardized extracts for wound healing?
Fresh Mikania micrantha leaves, as used in PNG traditional medicine, are applied directly to wounds and contain volatile compounds alongside their phenolic constituents. Standardized ethanolic extracts concentrate bioactive compounds like caffeic acid and benzyl glucosides, potentially offering more consistent potency, though fresh applications may provide additional benefits from unstandardized volatile components not preserved in extraction. The choice depends on whether traditional preparation methods or standardized dosing is preferred for topical wound support.
Who should avoid Mikania micrantha supplementation based on current safety data?
While Mikania micrantha is used in traditional medicine, limited clinical safety data means pregnant women, nursing mothers, and young children should exercise caution or consult healthcare providers before use. Individuals with known allergies to plants in the Asteraceae family may also experience sensitivities. Those taking anticoagulant or antiplatelet medications should consult a practitioner, as phenolic-rich herbs can theoretically influence platelet function.
How does the antioxidant strength of Mikania micrantha extracts compare to synthetic antioxidants used in supplements?
Mikania micrantha crude extracts demonstrate ABTS radical scavenging capacity (SC50 values as low as 0.31 µM) that exceeds L-ascorbic acid, placing it among potent botanical antioxidant sources. However, direct comparisons to synthetic antioxidants like BHT or BHA require equivalent assay conditions; botanical extracts often show superior performance in ABTS/FRAP assays but may have different bioavailability in vivo. The phenolic complexity of Mikania micrantha suggests broader antioxidant mechanisms than single-molecule synthetics, though human clinical evidence remains limited.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w mikania-micrantha-mile-a-minute-weed curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
